Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients With Hepatitis C
Asser Abou Elkassem, Brian C. Allen, Seth T. Lirette, Kelly L. Cox, Erick M. Remer, Perry J. Pickhardt, Meghan G. Lubner, Claude B. Sirlin, Timothy Dondlinger, Michael Schmainda, Robert B. Jacobus, Paige E. Severino, Andrew D. Smith
Abstract
The LSN score warrants a role in clinical practice as a quantitative marker for detecting advanced liver fibrosis, compensated cirrhosis, and decompensated cirrhosis and for predicting future liver-related events in patients with CLD from HCV.
Topics & Concepts
MedicineCirrhosisDecompensationGastroenterologyFibrosisInternal medicineLiver biopsyHepatitis CStage (stratigraphy)Liver diseaseRadiologyRetrospective cohort studyCohortTransient elastographyHepatitis C virusBiopsyHepatologyLiver fibrosisChronic liver diseaseChronic hepatitisHepatic fibrosisPredictive value of testsModel for End-Stage Liver DiseaseAutoimmune hepatitisHepatitisLiver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology